30.04.2013 • News • 3i • Azelis • Chemical Distribution

Azelis Announces Refinancing Deal

Today, speciality chemicals distributor Azelis announces that it has successfully secured an amend and extend refinancing package to deliver the company's new business plan. Under the new plan, the company's financing has been extended for a further 3 years at market interest rates.

In addition, the company's main shareholder 3i, and funds managed by 3i, have provided further equity support of €10 million, representing a significant contribution for the benefit of Azelis.

The deal reflects exceptional support from the banking community and from 3i for the new business plan and provides Azelis with strengthened liquidity and the financial resources to develop the business.

Free Virtual Event

Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.